BUZZ-Second Sight Medical Products: Retinal device gets Heath Canada approval

Mon Jan 12, 2015 11:16am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Medical device maker's shares up 8 pct at $11.74

** Receives Health Canada's approval for retinal implants to treat patients with outer retinal degeneration

** Company's Argus II Retinal Prosthesis is an electronic implant designed to improve vision in those with severe cases of the inherited disease

** Outer retinal degeneration is caused by progressive death of the cells in the region

** Argus II Retinal Prosthesis already approved in U.S.

** Up to Friday's close, stock had risen 20 pct since its debut on Nov. 19